ETNA, MARILENA PAOLA
ETNA, MARILENA PAOLA
A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients
2023-01-01 Severa, M; Rizzo, F; Sinigaglia, A; Ricci, D; Etna, Mp; Cola, G; Landi, D; Buscarinu, Mc; Valdarchi, C; Ristori, G; Riccetti, S; Piubelli, C; Palmerini, P; Rosato, A; Gobbi, F; Balducci, S; Marfia, Ga; Salvetti, M; Barzon, L; Coccia, Em
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection
2021-09-01 Severa, M; Diotti, Ra; Etna, Mp; Rizzo, F; Fiore, S; Ricci, D; Iannetta, M; Sinigaglia, A; Lodi, A; Mancini, N; Criscuolo, E; Clementi, M; Andreoni, M; Balducci, S; Barzon, L; Stefanelli, P; Clementi, N; Coccia, Em
Novel evidence of Thymosin ?1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model
2023-01-01 Ricci, D; Etna, Mp; Severa, M; Fiore, S; Rizzo, F; Iannetta, M; Andreoni, M; Balducci, S; Stefanelli, P; Palamara, At; Coccia, Em
Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients
2018-01-01 Giacomini, E; Rizzo, F; Etna, Mp; Cruciani, M; Mechelli, R; Buscarinu, Mc; Pica, F; D'Agostini, C; Salvetti, M; Coccia, Em; Severa, M
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2023 | A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients | Severa, M; Rizzo, F; Sinigaglia, A; Ricci, D; Etna, Mp; Cola, G; Landi, D; Buscarinu, Mc; Valdarchi, C; Ristori, G; Riccetti, S; Piubelli, C; Palmerini, P; Rosato, A; Gobbi, F; Balducci, S; Marfia, Ga; Salvetti, M; Barzon, L; Coccia, Em | Articolo su rivista | |
| 1-set-2021 | Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection | Severa, M; Diotti, Ra; Etna, Mp; Rizzo, F; Fiore, S; Ricci, D; Iannetta, M; Sinigaglia, A; Lodi, A; Mancini, N; Criscuolo, E; Clementi, M; Andreoni, M; Balducci, S; Barzon, L; Stefanelli, P; Clementi, N; Coccia, Em | Articolo su rivista | |
| 1-gen-2023 | Novel evidence of Thymosin ?1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model | Ricci, D; Etna, Mp; Severa, M; Fiore, S; Rizzo, F; Iannetta, M; Andreoni, M; Balducci, S; Stefanelli, P; Palamara, At; Coccia, Em | Articolo su rivista | |
| 1-gen-2018 | Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients | Giacomini, E; Rizzo, F; Etna, Mp; Cruciani, M; Mechelli, R; Buscarinu, Mc; Pica, F; D'Agostini, C; Salvetti, M; Coccia, Em; Severa, M | Articolo su rivista |